Hosted on MSN28d
EMA approves Takeda’s Takhzyro pre-filled pen option for HAE
The European Medicines Agency (EMA) has approved an additional 2 mL pre-filled pen option for subcutaneous administration of Takeda’s Takhzyro (lanadelumab), aimed at treating hereditary ...
pharmaphorum10y
Insulin glargine biosimilar approved in Europe
Lilly/Boehringer Ingelheim's insulin glargine product will be available in a pre-filled pen and cartridges for ... efficacy and safety compared to Lantus in people with type 1 and type 2 diabetes.